Trexquant Investment’s Boston Scientific BSX Stock Holding History

Trexquant Investment’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$533K	Buy	+8,500	New	+$680K	﹤0.01%	1450

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Trexquant Investment's BSX Position: Q1 2026 in Review

Trexquant Investment increased its Boston Scientific (BSX) stake by 21% in Q1 2026, buying an estimated $5.37M and bringing the position to 385,491 shares worth $24.2M. The position accounts for 0.17% of the portfolio, ranked #118.

Trexquant Investment first reported a position in BSX in Q4 2014 and has held it in 33 quarters since. The position peaked at $42.2M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Trexquant Investment held 385,491 shares of Boston Scientific worth $24.2M as of Q1 2026.
Trexquant Investment bought 67,145 Boston Scientific shares in Q1 2026, an estimated $5.37M.
Boston Scientific made up 0.17% of Trexquant Investment's portfolio in Q1 2026, its #118 holding.
Trexquant Investment first reported a position in Boston Scientific in Q4 2014 and has held it in 33 quarters since.
Trexquant Investment's Boston Scientific position peaked at $42.2M in Q3 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.